Whole Cell Cholera Vaccine Market 2027 by Type, End User and Geography | The Insight Partners

Whole Cell Cholera Vaccine Market Forecast to 2027 - Covid-19 Impact and Global Analysis By Type (Adult, Children); End User (Clinical Research Institutes, Hospital, Surgical Centers.) and Geography

Report Code: TIPRE00016407 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Killed whole-cell oral cholera vaccines are used in process of standard cholera control and prevention toolkit. Apart from the majors taken to control spread of cholera include the established water, sanitation, and hygiene interventions, surveillance, and case management. Currently available whole-cell killed oral cholera vaccines with a 2-dose schedule are efficient and effective for at least 3 years among adults. A new generation of whole-cell killed OCVs are available and have been shown to be safe, efficacious, and effective in multiple settings.

MARKET DYNAMICS

The Whole Cell Cholera Vaccine market is growing due to growing demand for vaccine and presence of large number market players. However the lack of proper supply chain for vaccine across the developing nations.

MARKET SCOPE

The "Whole Cell Cholera Vaccine Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Whole Cell Cholera Vaccine market with detailed market segmentation type and End user. The Whole Cell Cholera Vaccine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Whole Cell Cholera Vaccine market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Whole Cell Cholera Vaccine market is segmented on the basis of type and end user. Based on type, the market is segmented as adult and children. Based on the end user the market is segmented into Clinical Research Institutes, Hospital and Surgical Centers.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Whole Cell Cholera Vaccine market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Whole Cell Cholera Vaccine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Whole Cell Cholera Vaccine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Whole Cell Cholera Vaccine market in these regions.



Get more information on this report :

MARKET PLAYERS

The report covers key developments in the Whole Cell Cholera Vaccine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Whole Cell Cholera Vaccine market are anticipated to have lucrative growth opportunities in the future with the rising demand for Whole Cell Cholera Vaccine in the global market. Below mentioned is the list of few companies engaged in the Whole Cell Cholera Vaccine market.

The report also includes the profiles of key players in Whole Cell Cholera Vaccine market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- SBL Vaccine
- PaxVax
- Valneva SE
- GlaxoSmithKline
- Johnson and Johnson
- Merck
- Pfizer
- Sanofi Pasteur
- AstraZeneca(Medimmune, LLC.)
- Serum Institute of India Pvt.Ltd.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.



Get more information on this report :

TABLE OF CONTENTS

1.   INTRODUCTION
1.1.   SCOPE OF THE STUDY
1.2.   THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3.   MARKET SEGMENTATION
1.3.1   Whole Cell Cholera Vaccine Market - By Type
1.3.2   Whole Cell Cholera Vaccine Market - By End User
1.3.3   Whole Cell Cholera Vaccine Market - By Region
1.3.3.1   By Country

2.   KEY TAKEAWAYS

3.   RESEARCH METHODOLOGY

4.   WHOLE CELL CHOLERA VACCINE MARKET LANDSCAPE
4.1.   OVERVIEW
4.2.   PEST ANALYSIS
4.2.1   North America - Pest Analysis
4.2.2   Europe - Pest Analysis
4.2.3   Asia-Pacific - Pest Analysis
4.2.4   Middle East and Africa - Pest Analysis
4.2.5   South and Central America - Pest Analysis
4.3.   EXPERT OPINIONS

5.   WHOLE CELL CHOLERA VACCINE MARKET - KEY MARKET DYNAMICS
5.1.   KEY MARKET DRIVERS
5.2.   KEY MARKET RESTRAINTS
5.3.   KEY MARKET OPPORTUNITIES
5.4.   FUTURE TRENDS
5.5.   IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6.   WHOLE CELL CHOLERA VACCINE MARKET - GLOBAL MARKET ANALYSIS
6.1.   WHOLE CELL CHOLERA VACCINE - GLOBAL MARKET OVERVIEW
6.2.   WHOLE CELL CHOLERA VACCINE - GLOBAL MARKET AND FORECAST TO 2027
6.3.   MARKET POSITIONING/MARKET SHARE

7.   WHOLE CELL CHOLERA VACCINE MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1.   OVERVIEW
7.2.   TYPE MARKET FORECASTS AND ANALYSIS
7.3.   ADULT
7.3.1.   Overview
7.3.2.   Adult Market Forecast and Analysis
7.4.   CHILDREN
7.4.1.   Overview
7.4.2.   Children Market Forecast and Analysis
8.   WHOLE CELL CHOLERA VACCINE MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1.   OVERVIEW
8.2.   END USER MARKET FORECASTS AND ANALYSIS
8.3.   CLINICAL RESEARCH INSTITUTES
8.3.1.   Overview
8.3.2.   Clinical Research Institutes Market Forecast and Analysis
8.4.   HOSPITAL
8.4.1.   Overview
8.4.2.   Hospital Market Forecast and Analysis
8.5.   SURGICAL CENTERS.
8.5.1.   Overview
8.5.2.   Surgical Centers. Market Forecast and Analysis

9.   WHOLE CELL CHOLERA VACCINE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1.   NORTH AMERICA
9.1.1   North America Whole Cell Cholera Vaccine Market Overview
9.1.2   North America Whole Cell Cholera Vaccine Market Forecasts and Analysis
9.1.3   North America Whole Cell Cholera Vaccine Market Forecasts and Analysis - By Type
9.1.4   North America Whole Cell Cholera Vaccine Market Forecasts and Analysis - By End User
9.1.5   North America Whole Cell Cholera Vaccine Market Forecasts and Analysis - By Countries
9.1.5.1   United States Whole Cell Cholera Vaccine Market
9.1.5.1.1   United States Whole Cell Cholera Vaccine Market by Type
9.1.5.1.2   United States Whole Cell Cholera Vaccine Market by End User
9.1.5.2   Canada Whole Cell Cholera Vaccine Market
9.1.5.2.1   Canada Whole Cell Cholera Vaccine Market by Type
9.1.5.2.2   Canada Whole Cell Cholera Vaccine Market by End User
9.1.5.3   Mexico Whole Cell Cholera Vaccine Market
9.1.5.3.1   Mexico Whole Cell Cholera Vaccine Market by Type
9.1.5.3.2   Mexico Whole Cell Cholera Vaccine Market by End User
9.2.   EUROPE
9.2.1   Europe Whole Cell Cholera Vaccine Market Overview
9.2.2   Europe Whole Cell Cholera Vaccine Market Forecasts and Analysis
9.2.3   Europe Whole Cell Cholera Vaccine Market Forecasts and Analysis - By Type
9.2.4   Europe Whole Cell Cholera Vaccine Market Forecasts and Analysis - By End User
9.2.5   Europe Whole Cell Cholera Vaccine Market Forecasts and Analysis - By Countries
9.2.5.1   Germany Whole Cell Cholera Vaccine Market
9.2.5.1.1   Germany Whole Cell Cholera Vaccine Market by Type
9.2.5.1.2   Germany Whole Cell Cholera Vaccine Market by End User
9.2.5.2   France Whole Cell Cholera Vaccine Market
9.2.5.2.1   France Whole Cell Cholera Vaccine Market by Type
9.2.5.2.2   France Whole Cell Cholera Vaccine Market by End User
9.2.5.3   Italy Whole Cell Cholera Vaccine Market
9.2.5.3.1   Italy Whole Cell Cholera Vaccine Market by Type
9.2.5.3.2   Italy Whole Cell Cholera Vaccine Market by End User
9.2.5.4   Spain Whole Cell Cholera Vaccine Market
9.2.5.4.1   Spain Whole Cell Cholera Vaccine Market by Type
9.2.5.4.2   Spain Whole Cell Cholera Vaccine Market by End User
9.2.5.5   United Kingdom Whole Cell Cholera Vaccine Market
9.2.5.5.1   United Kingdom Whole Cell Cholera Vaccine Market by Type
9.2.5.5.2   United Kingdom Whole Cell Cholera Vaccine Market by End User
9.2.5.6   Rest of Europe Whole Cell Cholera Vaccine Market
9.2.5.6.1   Rest of Europe Whole Cell Cholera Vaccine Market by Type
9.2.5.6.2   Rest of Europe Whole Cell Cholera Vaccine Market by End User
9.3.   ASIA-PACIFIC
9.3.1   Asia-Pacific Whole Cell Cholera Vaccine Market Overview
9.3.2   Asia-Pacific Whole Cell Cholera Vaccine Market Forecasts and Analysis
9.3.3   Asia-Pacific Whole Cell Cholera Vaccine Market Forecasts and Analysis - By Type
9.3.4   Asia-Pacific Whole Cell Cholera Vaccine Market Forecasts and Analysis - By End User
9.3.5   Asia-Pacific Whole Cell Cholera Vaccine Market Forecasts and Analysis - By Countries
9.3.5.1   Australia Whole Cell Cholera Vaccine Market
9.3.5.1.1   Australia Whole Cell Cholera Vaccine Market by Type
9.3.5.1.2   Australia Whole Cell Cholera Vaccine Market by End User
9.3.5.2   China Whole Cell Cholera Vaccine Market
9.3.5.2.1   China Whole Cell Cholera Vaccine Market by Type
9.3.5.2.2   China Whole Cell Cholera Vaccine Market by End User
9.3.5.3   India Whole Cell Cholera Vaccine Market
9.3.5.3.1   India Whole Cell Cholera Vaccine Market by Type
9.3.5.3.2   India Whole Cell Cholera Vaccine Market by End User
9.3.5.4   Japan Whole Cell Cholera Vaccine Market
9.3.5.4.1   Japan Whole Cell Cholera Vaccine Market by Type
9.3.5.4.2   Japan Whole Cell Cholera Vaccine Market by End User
9.3.5.5   South Korea Whole Cell Cholera Vaccine Market
9.3.5.5.1   South Korea Whole Cell Cholera Vaccine Market by Type
9.3.5.5.2   South Korea Whole Cell Cholera Vaccine Market by End User
9.3.5.6   Rest of Asia-Pacific Whole Cell Cholera Vaccine Market
9.3.5.6.1   Rest of Asia-Pacific Whole Cell Cholera Vaccine Market by Type
9.3.5.6.2   Rest of Asia-Pacific Whole Cell Cholera Vaccine Market by End User
9.4.   MIDDLE EAST AND AFRICA
9.4.1   Middle East and Africa Whole Cell Cholera Vaccine Market Overview
9.4.2   Middle East and Africa Whole Cell Cholera Vaccine Market Forecasts and Analysis
9.4.3   Middle East and Africa Whole Cell Cholera Vaccine Market Forecasts and Analysis - By Type
9.4.4   Middle East and Africa Whole Cell Cholera Vaccine Market Forecasts and Analysis - By End User
9.4.5   Middle East and Africa Whole Cell Cholera Vaccine Market Forecasts and Analysis - By Countries
9.4.5.1   South Africa Whole Cell Cholera Vaccine Market
9.4.5.1.1   South Africa Whole Cell Cholera Vaccine Market by Type
9.4.5.1.2   South Africa Whole Cell Cholera Vaccine Market by End User
9.4.5.2   Saudi Arabia Whole Cell Cholera Vaccine Market
9.4.5.2.1   Saudi Arabia Whole Cell Cholera Vaccine Market by Type
9.4.5.2.2   Saudi Arabia Whole Cell Cholera Vaccine Market by End User
9.4.5.3   U.A.E Whole Cell Cholera Vaccine Market
9.4.5.3.1   U.A.E Whole Cell Cholera Vaccine Market by Type
9.4.5.3.2   U.A.E Whole Cell Cholera Vaccine Market by End User
9.4.5.4   Rest of Middle East and Africa Whole Cell Cholera Vaccine Market
9.4.5.4.1   Rest of Middle East and Africa Whole Cell Cholera Vaccine Market by Type
9.4.5.4.2   Rest of Middle East and Africa Whole Cell Cholera Vaccine Market by End User
9.5.   SOUTH AND CENTRAL AMERICA
9.5.1   South and Central America Whole Cell Cholera Vaccine Market Overview
9.5.2   South and Central America Whole Cell Cholera Vaccine Market Forecasts and Analysis
9.5.3   South and Central America Whole Cell Cholera Vaccine Market Forecasts and Analysis - By Type
9.5.4   South and Central America Whole Cell Cholera Vaccine Market Forecasts and Analysis - By End User
9.5.5   South and Central America Whole Cell Cholera Vaccine Market Forecasts and Analysis - By Countries
9.5.5.1   Brazil Whole Cell Cholera Vaccine Market
9.5.5.1.1   Brazil Whole Cell Cholera Vaccine Market by Type
9.5.5.1.2   Brazil Whole Cell Cholera Vaccine Market by End User
9.5.5.2   Argentina Whole Cell Cholera Vaccine Market
9.5.5.2.1   Argentina Whole Cell Cholera Vaccine Market by Type
9.5.5.2.2   Argentina Whole Cell Cholera Vaccine Market by End User
9.5.5.3   Rest of South and Central America Whole Cell Cholera Vaccine Market
9.5.5.3.1   Rest of South and Central America Whole Cell Cholera Vaccine Market by Type
9.5.5.3.2   Rest of South and Central America Whole Cell Cholera Vaccine Market by End User

10.   INDUSTRY LANDSCAPE
10.1.   MERGERS AND ACQUISITIONS
10.2.   AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3.   NEW PRODUCT LAUNCHES
10.4.   EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11.   WHOLE CELL CHOLERA VACCINE MARKET, KEY COMPANY PROFILES
11.1.   SBL VACCINE
11.1.1.   Key Facts
11.1.2.   Business Description
11.1.3.   Products and Services
11.1.4.   Financial Overview
11.1.5.   SWOT Analysis
11.1.6.   Key Developments
11.2.   PAXVAX
11.2.1.   Key Facts
11.2.2.   Business Description
11.2.3.   Products and Services
11.2.4.   Financial Overview
11.2.5.   SWOT Analysis
11.2.6.   Key Developments
11.3.   VALNEVA SE
11.3.1.   Key Facts
11.3.2.   Business Description
11.3.3.   Products and Services
11.3.4.   Financial Overview
11.3.5.   SWOT Analysis
11.3.6.   Key Developments
11.4.   GLAXOSMITHKLINE
11.4.1.   Key Facts
11.4.2.   Business Description
11.4.3.   Products and Services
11.4.4.   Financial Overview
11.4.5.   SWOT Analysis
11.4.6.   Key Developments
11.5.   JOHNSON AND JOHNSON
11.5.1.   Key Facts
11.5.2.   Business Description
11.5.3.   Products and Services
11.5.4.   Financial Overview
11.5.5.   SWOT Analysis
11.5.6.   Key Developments
11.6.   MERCK
11.6.1.   Key Facts
11.6.2.   Business Description
11.6.3.   Products and Services
11.6.4.   Financial Overview
11.6.5.   SWOT Analysis
11.6.6.   Key Developments
11.7.   PFIZER
11.7.1.   Key Facts
11.7.2.   Business Description
11.7.3.   Products and Services
11.7.4.   Financial Overview
11.7.5.   SWOT Analysis
11.7.6.   Key Developments
11.8.   SANOFI PASTEUR
11.8.1.   Key Facts
11.8.2.   Business Description
11.8.3.   Products and Services
11.8.4.   Financial Overview
11.8.5.   SWOT Analysis
11.8.6.   Key Developments
11.9.   ASTRAZENECA(MEDIMMUNE, LLC.)
11.9.1.   Key Facts
11.9.2.   Business Description
11.9.3.   Products and Services
11.9.4.   Financial Overview
11.9.5.   SWOT Analysis
11.9.6.   Key Developments
11.10.   SERUM INSTITUTE OF INDIA PVT.LTD.
11.10.1.   Key Facts
11.10.2.   Business Description
11.10.3.   Products and Services
11.10.4.   Financial Overview
11.10.5.   SWOT Analysis
11.10.6.   Key Developments

12.   APPENDIX
12.1.   ABOUT THE INSIGHT PARTNERS
12.2.   GLOSSARY OF TERMS
The List of Companies

1.SBL Vaccine
2.PaxVax
3.Valneva SE
4.GlaxoSmithKline
5.Johnson and Johnson
6.Merck
7.Pfizer
8.Sanofi Pasteur
9.AstraZeneca(Medimmune, LLC.)
10.Serum Institute of India Pvt.Ltd.
TIPRE00016407
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking